![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 401/14 | (2006.01) |
C07D 413/14 | (2006.01) | ||
C07D 401/06 | (2006.01) | ||
C07D 403/06 | (2006.01) | ||
C07D 417/14 | (2006.01) | ||
A61K 31/454 | (2006.01) | ||
A61K 31/4545 | (2006.01) | ||
A61K 31/5377 | (2006.01) | ||
A61P 27/00 | (2006.01) | ||
A61P 37/00 | (2006.01) |
(11) | Number of the document | 3022192 |
(13) | Kind of document | T |
(96) | European patent application number | 14744744.5 |
Date of filing the European patent application | 2014-07-14 | |
(97) | Date of publication of the European application | 2016-05-25 |
(45) | Date of publication and mention of the grant of the patent | 2017-10-11 |
(46) | Date of publication of the claims translation | 2017-12-14 |
(86) | Number | PCT/US2014/046515 |
Date | 2014-07-14 |
(87) | Number | WO 2015/009616 |
Date | 2015-01-22 |
(30) | Number | Date | Country code |
201361846355 P | 2013-07-15 | US | |
201461977028 P | 2014-04-08 | US |
(72) |
ADAMS, Christopher, US
CAPPARELLI, Michael Paul, US
EHARA, Takeru, US
KARKI, Rajeshri Ganesh, US
MAINOLFI, Nello, US
ZHANG, Chun, US
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Piperidinilindolo dariniai ir jų panaudojimas kaip komplemento faktoriaus B inhibitorių |
PIPERIDINYL INDOLE DERIVATIVES AND THEIR USE AS COMPLEMENT FACTOR B INHIBITORS |
Payment date | Validity (years) | Amount | |
2025-06-18 | 12 | 289.00 EUR |
2026-07-14 |